These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35759223)

  • 21. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
    Bölke E; Matuschek C; Fischer JC
    N Engl J Med; 2020 Oct; 383(17):1694-1695. PubMed ID: 32966710
    [No Abstract]   [Full Text] [Related]  

  • 22. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.
    Yang OO; Ibarrondo FJ
    N Engl J Med; 2020 Oct; 383(17):1697-1698. PubMed ID: 32966713
    [No Abstract]   [Full Text] [Related]  

  • 23. Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020.
    Panepinto JA; Brandow A; Mucalo L; Yusuf F; Singh A; Taylor B; Woods K; Payne AB; Peacock G; Schieve LA
    Emerg Infect Dis; 2020 Oct; 26(10):2473-2476. PubMed ID: 32639228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
    Shanmugaraj B; Siriwattananon K; Wangkanont K; Phoolcharoen W
    Asian Pac J Allergy Immunol; 2020 Mar; 38(1):10-18. PubMed ID: 32134278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City.
    Mansour M; Leven E; Muellers K; Stone K; Mendu DR; Wajnberg A
    J Gen Intern Med; 2020 Aug; 35(8):2485-2486. PubMed ID: 32495088
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area.
    Moscola J; Sembajwe G; Jarrett M; Farber B; Chang T; McGinn T; Davidson KW;
    JAMA; 2020 Sep; 324(9):893-895. PubMed ID: 32780804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City.
    Dumitriu D; Emeruwa UN; Hanft E; Liao GV; Ludwig E; Walzer L; Arditi B; Saslaw M; Andrikopoulou M; Scripps T; Baptiste C; Khan A; Breslin N; Rubenstein D; Simpson LL; Kyle MH; Friedman AM; Hirsch DS; Miller RS; Fernández CR; Fuchs KM; Keown MK; Glassman ME; Stephens A; Gupta A; Sultan S; Sibblies C; Whittier S; Abreu W; Akita F; Penn A; D'Alton ME; Orange JS; Goffman D; Saiman L; Stockwell MS; Gyamfi-Bannerman C
    JAMA Pediatr; 2021 Feb; 175(2):157-167. PubMed ID: 33044493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serological analysis of SARS Coronavirus in children diagnosed clinically as severe acute respiratory syndrome cases during SARS epidemic in Beijing].
    Zhao LQ; Qian Y; Zhu RN; Deng J; Wang F; Chen HZ; Cao L; Wang TY; Zhang T
    Zhonghua Er Ke Za Zhi; 2006 Apr; 44(4):262-6. PubMed ID: 16780645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A preliminary investigation on the serological and epidemiological characteristics of severe acute respiratory syndrome in children].
    Cao L; Wang TY; Chen HZ; Qian Y; Chen BW; Fang P; Sun YX; Zhu RN; Deng J; Zhao LQ; Mi J; Zhang T
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):840-4. PubMed ID: 15631713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality.
    Kelleni MT
    J Infect; 2021 Feb; 82(2):e35. PubMed ID: 32810520
    [No Abstract]   [Full Text] [Related]  

  • 31. Rapid Community Engagement in Response to SARS-CoV-2 Funding Opportunities: New York City, 2020‒2021.
    Williams NJ; Gill E; Punter MA; Reiss J; Goodman M; Shelley D; Thorpe LE
    Am J Public Health; 2022 Nov; 112(S9):S904-S908. PubMed ID: 36446061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2.
    Bates TA; Weinstein JB; Farley S; Leier HC; Messer WB; Tafesse FG
    Cell Rep; 2021 Feb; 34(7):108737. PubMed ID: 33545052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma.
    Lindholm PF; Ramsey G; Kwaan HC
    Semin Thromb Hemost; 2020 Oct; 46(7):796-803. PubMed ID: 32526774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of tocilizumab in multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2.
    Banday AZ; Vignesh P
    J Pediatr; 2021 Jan; 228():315. PubMed ID: 32979386
    [No Abstract]   [Full Text] [Related]  

  • 35. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
    Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
    Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful use of veno-venous extracorporeal membrane oxygenation for acute chest syndrome in a child with sickle cell disease and SARS-CoV-2.
    Koh W; Malik P; Whitehead J; Morales DLS; Hayes D
    Pediatr Pulmonol; 2022 Apr; 57(4):1096-1099. PubMed ID: 35072359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2.
    Chouchane L; Grivel JC; Farag EABA; Pavlovski I; Maacha S; Sathappan A; Al-Romaihi HE; Abuaqel SW; Ata MMA; Chouchane AI; Remadi S; Halabi N; Rafii A; Al-Thani MH; Marr N; Subramanian M; Shan J
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33529170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19).
    Baggio S; L'Huillier AG; Yerly S; Bellon M; Wagner N; Rohr M; Huttner A; Blanchard-Rohner G; Loevy N; Kaiser L; Jacquerioz F; Eckerle I
    Clin Infect Dis; 2021 Jul; 73(1):148-150. PubMed ID: 32761228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parental Coronavirus Disease 2019 Testing of Hospitalized Children: Rethinking Infection Control in a Pandemic.
    Hassoun A; Prasad N; Pugh S; Merced I; Abularrage J; Sharma M
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):564-565. PubMed ID: 32856705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
    Balanchivadze N; Kudirka AA; Askar S; Almadhoun K; Kuriakose P; Fadel R; Dabak V
    Hemoglobin; 2020 Jul; 44(4):284-289. PubMed ID: 32722950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.